Selgantolimod

Selgantolimod (GS-9688) 是一种口服活性，有效和选择性的 Toll 样受体 8 (TLR8) 激动剂，用于治疗乙型肝炎病毒 (HBV) 和 HIV 感染。

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
5mg

￥5937.00

4750.00

- +
10mg

￥10250.00

8200.00

- +
50mg

￥29925.00

23940.00

- +
100mg

￥43812.00

35050.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

Background

Selgantolimod (GS-9688) is an orally active, potent and selective toll-like receptor 8 (TLR8) agonist for the treatment of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infection[1][2][3].

[1]. Jules Levin. Efficacy and Safety of Oral TLR8 Agonist Selgantolimod in Virally Suppressed Adult Patients With Chronic Hepatitis B: a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study. 2019 Nov 8-12. [2]. Benjamin Ryan. Selgantolimod Shows Promise as Treatment for Hepatitis B. November 18, 2019. [3]. Romas Geleziunas, et al. Modulators of toll-like receptors for the treatment of hiv. US20170071944A1.